Insider buying last 90 days
No open-market insider purchases were filed for MS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Close on Sep 18, 2026. Page updated Sep 19, 9:14 pm ET.
Morgan Stanley shares close at $202.52, down 0.5%, sitting between the 50-day average of $214.34 and the 200-day average of $192.96. The stock is off 5.5% over the past month and 9.3% over three months, though it remains up 27.7% over six months and 28.7% over the past year. The GekkoIndex reads 69.5, placing the stock in the Accumulation zone, and price sits 9.3% below Gekko Fair Value of $223.18.
Coverage this week centers on Morgan Stanley's own research output rather than company-specific news about MS itself. Analysts at the firm issued a series of price target adjustments across utilities, trimming targets on CenterPoint Energy to $38.00, Dominion Energy to $66 from $68, and Ameren to $108 from $114, all while maintaining Equalweight ratings. Elsewhere, the firm reiterated a buy rating and $300 target on SpaceX citing AI compute potential, commented on Apple's iPhone demand and supply picture, and disclosed a passive stake amendment reducing its holding in Eaton Vance Senior Income Trust to 0.0%.
Looking ahead, Morgan Stanley reports earnings on 14 October 2026, 24 days out and within a typical 20-trading-day holding window; the prior quarter posted EPS of $3.46 against a $2.89 estimate, followed by a 4.1% reaction, with 8 beats in the last 8 quarters and average absolute moves of 3.6%. Congress recorded 2 buys and 0 sells over the past 90 days. Seasonality over the next 20 trading days has averaged 0% across 5 years, rising in 2 of them. The gap to Gekko Fair Value bears watching as the earnings date approaches.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Morgan Stanley scores 3 supportive, 2 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed1 headwind
Averages disagree
Close $202.52 sits between the 50-day ($214.34) and 200-day ($192.96) averages, or the averages disagree.
See the chart69.5, Accumulation
Reading 69.5 is in the Accumulation zone.
See the GekkoIndex9.3% below
Price is 9.3% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: Congress 2 buys / 0 sales.
See smart moneyReports in 24 days
Reports on Oct 14, 2026, 24 days away — inside a typical 20-trading-day hold.
See earnings0.0% on average
From this point in the calendar, the next 20 trading days averaged 0% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Morgan Stanley closed at $202.52 on Sep 18, 2026, +28.7% over the past year, inside a 52-week range of $151.84 to $232.25.
Use the left and right arrow keys to read daily values.
Put MS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Morgan Stanley is a financial holding company that provides a wide range of financial services to corporations, governments, financial institutions, and individual clients around the world, including the Americas, Europe, the Middle East, Africa, and Asia. It is known for its work in capital raising, financial advisory, and wealth management, serving as a link between large institutional needs and individual investor services.
The firm runs its business through three divisions. Institutional Securities handles underwriting, mergers and acquisitions advice, corporate restructuring, real estate and project financing, and sales and trading across equity, fixed income, currency, and commodity markets, along with lending and research services. Wealth Management serves individual investors and smaller businesses and institutions, offering brokerage, financial planning, workplace stock plans, insurance and annuity products, and various lending and banking services. Investment Management develops equity, fixed income, liquidity, and alternative investment products for institutional and intermediary clients such as pension plans, foundations, endowments, governments, sovereign wealth funds, insurers, and fund sponsors.
Morgan Stanley's shares are listed on the NYSE under the ticker MS.
Morgan Stanley’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 69.5, in the Accumulation zone, up 10.7 points over five sessions.
Up 10.7 points over five sessions, from the Neutral zone.
Reading for Sep 18, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 15 | +4.5% | +2.0% | ||
| Accumulation (current zone) | 111 | +0.6% | +4.8% | ||
| Neutral | 458 | +0.8% | +3.0% | ||
| Distribution | 74 | +0.1% | +1.3% | ||
| Selling | 4 | Too few readings yet | |||
Average MS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Morgan Stanley trades 9.3% below Gekko Fair Value of $223.18, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Morgan Stanley shares are worth, recalculated every trading day.
$223.18
Gekko Fair Value, Sep 19, 2026
9.3% Undervalued
No open-market insider purchases were filed for Morgan Stanley, and members of Congress disclosed 2 purchases and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for MS in the last 90 days.
From Form 4 filings, dated to when each was filed.
2trades disclosed: 2 purchases and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Daniel Milton Newhouse House, WA, purchase | $1,001 - $15,000 | Jul 20 traded Jul 10 |
| Daniel Milton Newhouse House, WA, purchase | $1,001 - $15,000 | Jul 20 traded Jul 9 |
From congressional disclosures, which report amounts as ranges.
Morgan Stanley has been buying back its own shares.
From company filings.
2of the funds Gekko tracks hold MS.
Morgan Stanley reports on Oct 14, 2026 (24 days away), and beat the EPS estimate in 8 of its last 8 reports.
Oct 14, 2026
24 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 15, 2026 | $3.46 est $2.89 | $21.35B est $19.67B | −4.1% |
| Apr 15, 2026 | $3.43 est $3.02 | $20.58B est $19.74B | +2.2% |
| Jan 15, 2026 | $2.68 est $2.40 | $17.89B est $17.74B | +4.6% |
| Oct 15, 2025 | $2.80 est $2.10 | $17.08B est $16.69B | +3.0% |
| Jul 16, 2025 | $2.13 est $1.98 | $15.60B est $16.07B | −0.5% |
| Apr 11, 2025 | $2.60 est $2.21 | $16.52B est $16.54B | +2.4% |
| Jan 16, 2025 | $2.22 est $1.69 | $15.04B est $15.03B | +5.6% |
| Oct 16, 2024 | $1.88 est $1.58 | $14.34B est $14.35B | +6.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Morgan Stanley is $236.43, +16.7% from the last close, from 16 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 16 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 16 | Barclays | $262 | +29.4% |
| Sep 15 | Goldman Sachs | $239 | +18.0% |
| Sep 8 | Goldman Sachs | $258 | +27.4% |
| Aug 6 | DBS | $250 | +23.4% |
| Aug 5 | Barclays | $262 | +29.4% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 19, Morgan Stanley averaged 0.0% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.5% | 3 of 5 |
| Next 10 trading days | −3.8% | 1 of 5 |
| Next 15 trading days | −3.5% | 1 of 5 |
| Next 20 trading days | 0.0% | 2 of 5 |
| Next 30 trading days | −0.1% | 3 of 5 |
For scale, MS’s typical 20-trading-day move in either direction is about 5.4%.
Morgan Stanley’s market cap is $319.4B, with a P/E ratio of 16.3 and revenue of $77.83B over the last twelve months.
Coverage of Morgan Stanley this week reads neutral: 7 positive, 14 neutral and 2 negative headlines.
Morgan Stanley’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| UBSUBS | Accumulation | 6.1% below |
| BLKBlackRock | Accumulation | 10.3% below |
| BXBlackstone | Accumulation | 9.5% below |
| KKRKKR | Accumulation | 13.2% below |
| BNBrookfield | Buying | 19.9% below |
| BAMBrookfield Asset Management | Buying | 12.7% below |
A peer links to its own page where one exists.
Morgan Stanley’s market cap is $319.4B at the Sep 18, 2026 close of $202.52, with 1.57B shares outstanding. The shares trade on a P/E ratio of 16.3.
The consensus analyst 12-month price target for Morgan Stanley is $236.43, +16.7% from the last close. Of the 16 firms that rated the stock in the last 90 days, 9 rate it a buy, 6 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Morgan Stanley is undervalued: the Sep 18, 2026 close of $202.52 is 9.3% below Gekko Fair Value of $223.18. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Morgan Stanley is expected to report on Oct 14, 2026 (24 days away). Analysts expect earnings of $3.13 per share on revenue of $20.36B. Morgan Stanley beat the earnings estimate in 8 of its last 8 reports, moving 3.6% on average across the report.
Morgan Stanley’s 52-week high is $232.25 and its 52-week low is $151.84; it closed at $202.52 on Sep 18, 2026, +28.7% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (gekkoindex, fair value and smart money), 2 as mixed (trend and seasonality) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.